Sleep disorders are problematic for persons with dementia and their family caregivers. This randomized controlled trial with crossover evaluated the effects of an innovative blue-white light therapy on 17 pairs of home-dwelling persons with dementia and their caregivers. Subjects with dementia received blue-white light and control (‘red-yellow’ light) for six weeks separated by a four-week washout. Neither actigraphic nor most self-reported sleep measures significantly differed for subjects with dementia. For caregivers, both sleep and role strain improved. No evidence of retinal light toxicity was observed. Six weeks of modest doses of blue-white light appear to improve sleep in caregivers but not in persons with dementia. Greater or prolonged circadian stimulation may be needed to determine if light is an effective treatment for persons with dementia.
Get full access to this article
View all access options for this article.
References
1.
BliwiseDL. Observed sleep/wakefulness and severity of dementia in an Alzheimer’s disease special care unit. Journal of Gerontology Series A: Biological Science and Medical Science1995; 50: M303–M306.
2.
BliwiseDL. Sleep in normal aging and dementia. Sleep1993; 16: 40–81.
3.
McKibbinCLAncoli-IsraelSDimsdaleJArchuletaCvon KanelRMillsP PattersonTLGrantI. Sleep in spousal caregivers of people with Alzheimer’s disease. Sleep2005; 28: 1245–1250.
4.
Willette-MurphyKToderoCYeaworthR. Mental health and sleep of older wife caregivers for spouses with Alzheimer’s disease and related disorders. Issues in Mental Health Nursing2006; 27: 837–852.
5.
von KanelRDimsdaleJEAncoli-IsraelSMillsPJPattersonTLMcKibbinCLArchuletaCGrantI. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. Journal of the American Geriatrics Society2006; 54: 431–437.
6.
MorinCMColecchiCStoneJASoodRBrinkD. Behavioral and pharmacological therapies for late-life insomnia. JAMA1999; 11: 991–999.
7.
MeulemanJRNelsonRCClarkRL. Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population. Annals of Pharmacotherapy1987; 21: 716–720.
8.
ChavezB. Pharmacotherapy in managing insomnia. US Pharmacist2005; 30: 23–26.
9.
TinettiME. Preventing falls in elderly persons. New England Journal of Medicine2003; 348: 42–49.
10.
TinettiMESpeechleyMGinterSF. Risk factors of falls among elderly persons living in the community. New England Journal of Medicine1988; 319: 1701–1707.
11.
CummingRGKlinebergJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Medical Journal of Australia1993; 158: 414–417.
12.
RayWAGriffinRMDowneyW. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA1989; 262: 3303–3307.
13.
AllainHBentue-FerrerDPolardEAkwaYPatatA. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly. Drugs and Aging2005; 22(9): 749–765.
14.
GlassJLanctotKLHerrmannNSprouleBABustoUE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ2005; 331: 1169–1169.
15.
SchenckCHMahowaldMWSackRL. Assessment and management of insomnia. JAMA2003; 289: 532–534.
16.
BaskettJJBroadJBWoodPCDuncanJRPledgerMJEnglishJArendtJ. Does melatonin improve sleep in older people? A randomized crossover trial. Age and Ageing2003; 32: 164–170.
17.
SingerCTractenbergREKayeJSchaferKGamstAGrundmanMThomasRThalLJ. Alzheimer’s Disease Cooperative Study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep2003; 26: 893–901.
18.
SerfatyMKennell-WebbSWarnerJBilizardRRavenP. Double blind randomized placebo controlled trial of low dose melatonin for sleep disorders in dementia. International Journal of Geriatric Psychiatry2002; 17: 1120–1127.
19.
GehrmanPRConnorDJMartinJLShochatTCorey-BloomJAncoli-IsraelS. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. American Journal of Geriatric Psychiatry2009; 17(2): 166–169.
20.
PrinzPNPeskindERVitalianoPPRaskindMAEisdorferCZemcuznikovN. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. Journal of the American Geriatrics Society1982; 30: 86–93.
Van SomerenEJWHagebeukEELijzengaCScheltensPde RooijSEJonkerCPotAMMirmiranMSwaabDF. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biological Psychiatry1996; 40: 259–270.
23.
Van SomerenEJWRaymannRJScherderEJDaanenHASwaabDF. Circadian and age-related modulation of thermoreception and temperature regulation: mechanisms and functional implications. Ageing Research Reviews2002; 1: 721–778.
24.
ZhouQPJungLRichardsKC. The management of sleep and circadian disturbance in patients with dementia. Current Neurology and Neuroscience Reports2012; 12: 193–204.
25.
McCurrySMPikeKCVitielloMVLogsdonRGLarsonEBTeriL. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trial. Journal of the American Geriatrics Society2011; 59: 1393–1402.
26.
LovellBAncoli-IsraelSGevirtzR. Effect of bright light treatment on agitated behavior in institutionalized elderly subjects. Psychiatry Research1995; 57: 7–12.
27.
BuysseDJReynoldsCFIIIMonkTHBermanSRKupferDJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research1989; 28(2): 193–213.
28.
MunchMScheuermaierKDZhangRDunneSPGuzikAMSilvaEJRondaJMDuffyJF. Effects on subjective and objective alertness and sleep in response to evening light exposure in older subjects. Behavioral Brain Research2011; 224: 272–278.
29.
GammackJ. Light therapy for insomnia in older adults. Clinics in Geriatric Medicine2008; 24: 139–149.
30.
MishimaKOkawaMHishikawaYHozumiSHoriHTakahashiK. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatrica Scandinavica1994; 89: 1–7.
31.
MishimaKHishikawaYOkawaM. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s type. Chronobiology International1998; 15: 647–654.
32.
Ancoli-IsraelSMartinJShochatTMarlerM. Morning light delays activity acrophase in demented elderly. Society for Light Treatment and Biological Rhythms2000; 12: 15–15.
33.
KoyamaEMatsubaraHNakanoT. Bright light treatment for sleep-wake disturbances in aged individuals with dementia. Psychiatry and Clinical Neurosciences1999; 53: 227–229.
34.
LyketsosCGLindell VeielLBakerASteeleC. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. International Journal of Geriatric Psychiatry1999; 14: 520–525.
35.
SloanePDWilliamsCSMitchellCMPreisserJSWoodWBarrickALHickmanSEGillKSConnellBREdingerJZimmermanS. High-intensity environmental light in dementia: effect on sleep and activity. Journal of the American Geriatrics Society2007; 55: 1524–1533.
36.
Riemersma-van der LekRFSwaabDFTwiskJHolEMHoogendijkWJvan SomerenEJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA2008; 299: 2642–2655.
37.
ForbesDCulumILischkaARMorganDGPeacockSForbesJForbesS. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. Cochrane Database of Systematic Revues2009;4:CD003946.
38.
BrainardGCHanifinJPGreesonJMByrneBGlickmanGGernerERollagMD. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. Journal of Neuroscience2001; 21: 6405–6412.
39.
ThapanKArendtJSkeneDJ. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. Journal of Physiology2001; 535(Pt 1): 261–267.
40.
WrightHRLackLC. Effect of light wavelength on suppression and phase delay of the melatonin rhythm. Chronobiology International2001; 18: 801–808.
41.
MoritaTTokuraH. Effects of lights of different color temperature on the nocturnal changes in core temperature and melatonin in humans. Applied Human Science1996; 15: 243–246.
42.
MontgomeryPDennisJ. Bright light therapy for sleep problems in adults aged 60+. Cochrane Database of Systematic Revues2002; 2: CD003403–CD003403.
43.
AlgverePVMarshallJSeregardS. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmologica Scandinavica2006; 84: 4–15.
44.
FolsteinMFFolsteinSEMcHughPR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research1975; 12: 189–198.
45.
ReaMSFigueiroMGBulloughJDBiermanA. A model of phototransduction by the human circadian system. Brain Research Reviews2005; 50: 213–228.
46.
ReaMSFigueiroMGBiermanAHammerR. Modeling the spectral sensitivity of the human circadian system. Lighting Research and Technology2012; 44: 386–396.
47.
HaysRDMartinSASestiAMSpritzerKL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Medicine2005; 6: 41–44.
48.
JohnsMW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep1991; 14: 540–545.
49.
AlexopoulosGSAbramsRCYoungRCShamoianCA. Cornell scale for depression in dementia. Biological Psychiatry1988; 23: 271–284.
50.
SpitzerRLKroenkeKWilliamsJBW. Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA1999; 282: 1737–1744.
51.
KroenkeKSpitzerRLWilliamsJBW. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine2001; 16: 606–613.
52.
LogsdonRGGibbonsLEMcCurrySMTeriL. Quality of life in Alzheimer’s disease: patient and caregiver reports. Journal of Mental Health and Aging1999; 5: 21–32.
53.
LogsdonRGGibbonsLEMcCurrySMTeriL. Assessing quality of life in older adults with cognitive impairment. Psychosomatic Medicine2002; 64: 510–519.
54.
KinneyJMStephensMA. Caregiving Hassles Scale: assessing the daily hassles of caring for a family member with dementia. The Gerontologist1989; 20: 649–655.
55.
ZaritSHReeverKEBach-PetersonJ. Relatives of the impaired elderly: correlates of feelings of burden. The Gerontologist1980; 20: 649–655.
56.
ZaritSHAnthonyCRBoutselisM. Interventions with care givers of dementia patients: comparison of two approaches. Psychology and Aging1987; 2: 225–232.
57.
WhitlatchCJZaritSHvon EyeA. Efficacy of interventions with caregivers: a reanalysis. The Gerontologist1991; 31: 9–14.
58.
KatzSFordABMoskowitzRWJacksonBAJaffeMW. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA1963; 185: 914–919.
59.
LawtonMPBrodyEM. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist1969; 9: 179–186.
60.
World Medical Association. World Medical Association Declaration of Helsinki. JAMA2000; 284: 3043–3045.
61.
ReaMSFigueiroMGBiermanABulloughJD. Circadian light. Journal of Circadian Rhythms2010; 8: 2–2.
62.
Lighting Research Center – Rensselaer Polytechnic Institute. Dimesimeter – light and activity measurement system description and calibration. Troy, NY: Rensselaer Polytechnic Institute, 2011 updated 2 September 2011; Retrieved 19 October 2011, from http://www.lrc.rpi.edu/programs/lightHealth/pdf/DimesimeterDoc.pdf.
63.
FigueiroMGHamnerRBiermanAReaMS. Comparisons of three practical field devices used to measure personal light exposures and activity levels. Lighting Research and Technology2013; 45: 421–424.
64.
van SomerenEJWKesslerAMirmirannMMirmirannMSwaabDF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biological Psychiatry1997; 41: 955–963.
65.
Alzheimer’s Association. 2012 Alzheimer’s disease facts and figures. Alzheimer’s and Dementia: Journal of the Alzheimer’s Association 2012; 8: 131–168.
